3-Day: Ketamine Assisted Psychotherapy Training: Become a Provider of Safe and Legal Psychedelic Therapy for Treatment Resistant PTSD, Anxiety and Depression
Program Information
Objectives
Describe research into synergistic actions between ketamine and psychotherapy to prolong clinically significant reductions in anxiety, trauma and depressive symptoms.
Investigate the outcomes of current clinical trials for Ketamine Assisted Psychotherapy effectiveness.
Describe medical and mental health contraindications to KAP and possible side effects.
Determine how various routes of ketamine administration and dosing options impact bioavailability and resulting treatment.
Conceptualize the patient screening and intake process for KAP.
Analyze critical liability, off-label use and scope of practice issues to ensure safe, ethical and legal KAP.
Utilize appropriate informed consent and safety protocols in KAP.
Build a KAP practice that properly accounts for important aspects of documentation, scheduling and billing.
Develop a treatment plan that establishes feelings of safety and trust during the different stages of KAP to enhance level of therapeutic engagement.
Apply strategies to better support people in altered states and encourage transformative experiences during those states.
Investigate potential benefits of therapeutic touch during the KAP process and explore consent and implementation issues.
Develop a plan to intervene when challenging emotional and spiritual experiences arise during a ketamine session
Utilize “set” and “setting” considerations when using KAP to create a that is controlled, comfortable and safe therapeutic container for patients.
Create treatment plans that pair evidence-based treatment modalities with Ketamine Assisted Psychotherapy.
Describe steps to handle boundary issues and other ethical considerations within KAP and psychedelic psychotherapy.
Develop a plan to manage common transference/counter transference themes in working with KAP.
Employ follow-up methods and questions to ensure effective integration is taking place following a KAP session.
Formulate a plan for therapist self-care and self-management in KAP and psychedelic psychotherapy
Outline
Current Research on Ketamine-Assisted Psychotherapy
Current clinical trials for KAP
Ketamine's historic use and how its psychiatric benefits were discovered
Future directions and questions
Treatment risks and limitations
Ketamine Assisted Psychotherapy vs. Therapeutic Ketamine Infusion
Preparation for Ketamine Assisted Psychotherapy
What to expect during KAP sessions
Verbalizing clear boundaries and how to support people in altered states
Differences between trance experiences and mystical experiences
Ketamine Pharmacodynamics
Glutamate receptor matrix: NMDA antagonism (& what this means)
Potential drug-to-drug interactions
Mechanism of action (MOA)
Routes of administration & Bioavailability
Set and Setting — Ecology of the KAP space
Discussing boundaries & ground rules with patients
Creating a safe container (i.e. "setting")
Mindset of client (i.e. "set")
Ceremony (e.g. opening & closing each KAP session with intention)
Psychotherapeutic Approaches During KAP Sessions
Exploring the difference between the sitter, guide, or therapist models
Identifying and engaging transference and countertransference
Quiet presence, attunement, holding space
Exploration of other evidence-based treatment modalities that pair well with KAP
Integration after Experiences with Non-Ordinary States of Consciousness
Healing in community, the power of integration groups, and how to facilitate them
Right and left brain nonverbal processing
Integration activities to do with clients or to recommend they do alone
Key Steps to Safe and Legal Ketamine-Assisted Psychotherapy and Integration Work
Liability, off-label use, and scope of practice
What you need to know about informed consent and safety protocols
Tips and guidance on how to partner with medical prescribers